Correction to: Anticancer potential of metformin: focusing on gastrointestinal cancers.

Khezri, Mohammad Rafi; Malekinejad, Hassan; Majidi-Zolbanin, Naime; Ghasemnejad-Berenji, Morteza.

Afiliação

Khezri MR; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, PO Box: 5715799313, Urmia, Iran.
Malekinejad H; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, PO Box: 5715799313, Urmia, Iran. malekinejad.h@umsu.ac.ir.
Majidi-Zolbanin N; Experimental and Applied Pharmaceutical Sciences Research Center, Urmia University of Medical Sciences, Urmia, Iran. malekinejad.h@umsu.ac.ir.
Ghasemnejad-Berenji M; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, PO Box: 5715799313, Urmia, Iran.

Cancer Chemother Pharmacol ; 89(2): 283, 2022 Feb.

Article em En | MEDLINE | ID: mdl-34338811

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article